Unknown

Dataset Information

Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics.


ABSTRACT: Although currently available treatment options for age-related macular degeneration (AMD) are limited, particularly for atrophic AMD, the identification of predisposing genetic variations has informed clinical studies addressing therapeutic options such as complement inhibitors and anti-inflammatory agents. To lower risk of early AMD, recommended lifestyle interventions such as the avoidance of smoking and the intake of low glycemic antioxidant-rich diets have largely followed from the identification of nongenetic modifiable factors. On the other hand, the challenge of understanding the complex relationship between aging and cumulative damage leading to AMD has fueled investigations of the visual cycle adducts that accumulate in retinal pigment epithelial (RPE) cells and are a hallmark of

SUBMITTER: Sparrow JR 

PROVIDER: S-EPMC4855581 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature